EDSA Edesa Biotech Corp: Uzoq muddatli qarzning kapitalga koeffitsiyenti
Edesa Biotech, Inc. (EDSA) teri va o'pka kasalliklarini davolash uchun tizimli yallig'lanishga qarshi terapiyalarni ishlab chiqishga e'tibor qaratadi. Immun javoblarini nazorat qilish uchun antitanachlarning ishlab chiqilishi kompaniyaga uzoq muddatli daromadlarni va'da qiladi, laboratoriya imkoniyatlari esa klinik sinovlar uchun to'liq ishlatilmoqda. Uzoq muddatli kapital tuzilmasi ko'rsatkichi bozor reaksiyasini aks ettiradi, bunda 0.00 qarz mablag'lari va kengayish o'rtasidagi muvozanatni belgilovchi baza parametr qiymati vazifasini bajaradi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_EDSA_-_Edesa-Biotech-Inc._-_Long-Term-Debt-to-Capital "EDSA: Edesa Biotech Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
Edesa Biotech, Inc. (EDSA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Edesa Biotech, Inc.|EDSA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati edesabiotech.com|EDSA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Edesa Biotech, Inc.|EDSA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Edesa Biotech
Kompaniyaning dastlabki tahlili:EDSA, Edesa Biotech Inc
Kredit risklarini minimallashtirish uchun investor emitentning qarz yuklamasini baholashi muhimdir. Ushbu koeffitsient uzoq muddatli majburiyatlarning umumiy kapitalga nisbati sifatida hisoblanadi. Bir yildan ortiq muddatli kreditlarning kapitalga nisbatini tahlil qilish biznesning moliyaviy avtonomiyasini aniqlash imkonini beradi. Past qiymatlar majburiyatlar tuzilmasining barqarorligini tasdiqlaydi. Edesa Biotech, Inc. (EDSA) uchun bu ARDS va teri patologiyalariga qarshi dori vositalarini ishlab chiqishni moliyalashtirishda juda muhimdir.
Toʻgʻridan-toʻgʻri raqobatchilar
Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati argenx N.V.|BioNTech Group (BNTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Abivax S.A. (ABVX)|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|protagonist-inc.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunovant (IMVT)|KNSA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|GRFS (Grifols Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adaptive Biotechnologies Inc. (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Vera Therapeutics Inc (VERA)|Uzoq muddatli qarzning kapitalga nisbati DNTH|Pharvaris Pharma - Uzoq muddatli qarzdorlikning kapitalga nisbati|ABCL: Uzoq muddatli qarzning o'z kapitaliga nisbati|TRML: Uzoq muddatli qarzning o'z kapitaliga nisbati|PGEN (Precigen) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|NKTR (Nektar) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati UPB|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc ZBIO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi immunome.com (IMNM)|GOSS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati KalVista Pharma KALV|SEPN (Septerna Corp) - Uzoq muddatli qarzning kapitalga nisbati|PVLA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Savara Inc.|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati ANAB (AnaptysBio)|Uzoq muddatli majburiyatlarning kapitalga nisbati ATXS|ENGN (enGene Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati rapt.com (RAPT)|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|ACRS - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Kyverna Therapeutics, Inc. (KYTX)|TLSA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Cabaletta Bio, Inc (CABA) - Uzoq muddatli qarzning kapitalga nisbati|Ventyx Biosciences, Inc (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati AVTX|Eledon Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Agenus, Inc. AGEN|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. (CLYM)|Uzoq muddatli kreditlarning kapitalga nisbati zurabio.com ZURA|ATYR (aTyr Pharma, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|ADAG - Uzoq muddatli majburiyatlarning kapitalga nisbati|IMA (ikenaoncology.com) - Uzoq muddatli qarzning kapitalga nisbati|Shattuck Labs (STTK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|EQ - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Connect Pharma (CNTB)|Immunic, Inc. (IMUX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti atarabio.com (ATRA)|Uzoq muddatli qarzning kapitalga nisbati IFRX|X4 Pharmaceuticals Inc. - Uzoq muddatli qarzdorlikning kapitalga nisbati|Adicet (ACET) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|INMB (INmune Bio, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati barinthusbio.com|KZR: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics plc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati enlivex.com (ENLV)|QTTB - Uzoq muddatli qarzning kapitalga nisbati|geovax.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati IBIO (iBio)|CARM - Uzoq muddatli qarzdorlikning kapitalga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|BOLT (Bolt Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc. HCWB|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Aptevo|AIM ImmunoTech (AIM) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti aditxt.com (ADTX)|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|XORTX Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vyome Holdings Inc (HIND)|REVB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics (AFMD)|Allakos Inc. (ALLK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti hookipapharma.com (HOOK)|Uzoq muddatli qarzning kapitalga nisbati IGMS|iTeos Therapeutics Inc - Uzoq muddatli qarzdorlikning kapitalga nisbati|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|TCBP: Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD (Third Harmonic Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati